当前位置:首页 - 行情中心 - 永安药业(002365) - 财务分析 - 现金流量表

永安药业

(002365)

  

流通市值:30.64亿  总市值:36.81亿
流通股本:2.45亿   总股本:2.95亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金196,635,490.26832,727,212.11604,670,318.15393,496,343.75
  收到的税费返还8,067,644.8123,469,372.9218,198,428.713,486,863.47
  收到其他与经营活动有关的现金884,219.6514,435,234.2424,002,348.122,355,922.77
  经营活动现金流入小计205,587,354.72870,631,819.27646,871,094.97409,339,129.99
  购买商品、接受劳务支付的现金148,034,050.03534,171,092.27377,848,425.62253,628,438.71
  支付给职工以及为职工支付的现金40,166,984.63119,341,802.8692,699,788.5867,744,885.66
  支付的各项税费6,113,412.9923,539,264.0618,644,318.1213,397,465.24
  支付其他与经营活动有关的现金12,704,683.3454,496,241.1459,013,673.7723,386,789.76
  经营活动现金流出小计207,019,130.99731,548,400.33548,206,206.09358,157,579.37
  经营活动产生的现金流量净额-1,431,776.27139,083,418.9498,664,888.8851,181,550.62
二、投资活动产生的现金流量:
  收回投资收到的现金253,891,659.541,057,033,842.43758,986,464.57380,710,244.38
  取得投资收益收到的现金4,405,420.5328,009,702.2420,299,520.839,603,224.08
  处置固定资产、无形资产和其他长期资产收回的现金净额-364,095.88,6672,717
  投资活动现金流入小计258,297,080.071,085,407,640.47779,294,652.4390,316,185.46
  购建固定资产、无形资产和其他长期资产支付的现金41,433,774.6562,277,086.9344,045,461.5332,199,901.95
  投资支付的现金191,296,918.191,143,180,134.33845,330,607.59442,121,223.62
  投资活动现金流出小计232,730,692.841,205,457,221.26889,376,069.12474,321,125.57
  投资活动产生的现金流量净额25,566,387.23-120,049,580.79-110,081,416.72-84,004,940.11
三、筹资活动产生的现金流量:
  吸收投资收到的现金-2,500,000--
  取得借款收到的现金-15,000,00015,000,00015,000,000
  收到其他与筹资活动有关的现金---780,723.23
  筹资活动现金流入平衡项目-000
  筹资活动现金流入小计-17,500,00015,000,00015,780,723.23
  偿还债务支付的现金-54,500,00026,150,00021,000,000
  分配股利、利润或偿付利息支付的现金-29,882,099.3229,661,234.34495,348.64
  支付其他与筹资活动有关的现金-43,292,817.5435,192,817.5416,292,817.54
  筹资活动现金流出平衡项目-000
  筹资活动现金流出小计-127,674,916.8691,004,051.8837,788,166.18
  筹资活动产生的现金流量净额平衡项目-000
  筹资活动产生的现金流量净额--110,174,916.86-76,004,051.88-22,007,442.95
四、汇率变动对现金及现金等价物的影响-1,506,585.831,321,512.161,850,474.491,865,228.08
五、现金及现金等价物净增加额22,628,025.13-89,819,566.55-85,570,105.23-52,965,604.36
  加:期初现金及现金等价物余额230,585,726.41320,405,292.96320,405,292.96320,405,292.96
  期末现金及现金等价物余额253,213,751.54230,585,726.41234,835,187.73267,439,688.6
补充资料:
  净利润-7,190,064.51-8,556,158.69
  资产减值准备-16,527,392.86-444,891
  固定资产和投资性房地产折旧-113,332,466.25-55,287,353.69
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-113,332,466.25-55,287,353.69
  无形资产摊销-3,504,499.84-1,729,949.17
  处置固定资产、无形资产和其他长期资产的损失--185,682.47--32,631.44
  固定资产报废损失-185,454.28--
  公允价值变动损失-1,085,650.93--2,004,491.16
  财务费用-941,505.85--658,520.54
  投资损失--30,560,208.94--11,461,930.22
  递延所得税--10,816,976.04--3,238,406.82
  其中:递延所得税资产减少--5,570,985.66--1,763,382.57
    递延所得税负债增加--5,245,990.38--1,475,024.25
  存货的减少-3,631,426.79--7,052,303.73
  经营性应收项目的减少-39,577,796.94-31,376,196.77
  经营性应付项目的增加--5,205,748.18--20,294,174.27
  现金的期末余额-230,585,726.41-267,439,688.6
  减:现金的期初余额-320,405,292.96-320,405,292.96
  现金及现金等价物的净增加额--89,819,566.55--52,965,604.36
公告日期2026-04-302026-04-172025-10-302025-08-28
审计意见(境内)标准无保留意见
TOP↑